Alternative Cancer, Clinical Use

Tumor vaccines in 2010: need for integration.

Cell Immunol. 2010;263(2):138-47. Epub 2010 Apr 3.

Koos D, Josephs SF, Alexandrescu DT, Chan RC, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Riordan NH, Carrier E.

Abstract

Induction of tumor-specific immunity is an attractive approach to cancer therapy, however to date every major pivotal trial has resulted in failure. While the phenomena of tumor-mediated immune suppression has been known for decades, only recently have specific molecular pathways been elucidated, and for the first time, rationale means of intervening and observing results of intervention have been developed. In this review we describe major advances in our understanding of tumor escape from immunological pressure and provide some possible therapeutic scenarios for enhancement of efficacy in future cancer vaccine trials.

link to full text

Induction of antitumor immunity through xenoplacental immunization.

Alternative Cancer

Improved microplate fluorometer counting of viable tumor and normal cells.

Alternative Cancer, Clinical Use

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.

Alternative Cancer, Clinical Use, Vitamin C

The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary.

Alternative Cancer, Clinical Use

Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.

Alternative Cancer, Clinical Use, Vitamin C

Inhibition of human breast carcinoma cell proliferation by ascorbate and copper.

Alternative Cancer, Clinical Use, Vitamin C

Orthomolecular oncology: a mechanistic view of intravenous ascorbate’s chemotherapeutic activity.

Alternative Cancer, Vitamin C

Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.

Alternative Cancer, Clinical Use, Supplements

Intravenous ascorbic acid: protocol for its application and use.

Alternative Cancer, Clinical Use, Vitamin C

L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.

Alternative Cancer, Clinical Use, Vitamin C

Cell membrane fatty acid composition differs between normal and malignant cell lines.

Alternative Cancer

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Alternative Cancer, Clinical Use, Vitamin C

Orthomolecular oncology review: ascorbic acid and cancer 25 years later.

Alternative Cancer, Clinical Use, Vitamin C

Cancer is a functional repair tissue.

Alternative Cancer

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

Alternative Cancer, Clinical Use, Vitamin C

Safety of targeting tumor endothelial cell antigens.

Alternative Cancer, Umbilical Cord

Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics.

Alternative Cancer

Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer.

Alternative Cancer, Clinical Use, Vitamin C

Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.

Alternative Cancer, Clinical Use, Vitamin C

Exosomes as a tumor immune escape mechanism: possible therapeutic implications.

Alternative Cancer, Clinical Use

Granulocyte activity in patients with cancer and healthy subjects.

Alternative Cancer

Anti-angiogenic effect of high doses of ascorbic acid.

Alternative Cancer, Clinical Use, Vitamin C

Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo.

Adipose (Fat), Alternative Cancer, Vitamin C

Immunotherapy for melanoma: current status and perspectives.

Alternative Cancer, Clinical Use

On the missing link between inflammation and cancer.

Alternative Cancer

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Alternative Cancer, Clinical Use

The bio-energetic theory of carcinogenesis.

Alternative Cancer

Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis.

Alternative Cancer, Vitamin C

Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.

Alternative Cancer, Clinical Use

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.

Alternative Cancer, Clinical Use, Vitamin C